Tumor Immune Microenvironment and Nivolumab Efficacy in EGFR Mutation–Positive Non–Small Cell Lung Cancer Based on T790M Status after Disease Progression During EGFR-TKI Treatment
Haratani, K., Hayashi, H., Tanaka, T., Kaneda, H., Togashi, Y., Sakai, K., Hayashi, K., Tomida, S., Chiba, Y., Yonesaka, K., Nonagase, Y., Takahama, T., Tanizaki, J., Tanaka, K., Yoshida, T., TanimuraLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx183
Date:
April, 2017
File:
PDF, 1.07 MB
english, 2017